Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19

Gazi University42 enrolled

Overview

In literature, there is no data evaluating respiratory functions in volleyball players during Covid-19 pandemic. The aim of this study is to evaluate and compared pulmonary functions, respiratory muscle strength, body compositions and performance situations perceptions in female volleyball players with Covid-19 and non-Covid-19.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Covid19

Interventions

Respiratory functionsOTHER

Respiratory muscle strength, pulmonary functions and body composition were evaluated in volleyball players

Eligibility

Sex: FEMALEMin age: 15 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * having passed at least 30 days after the Polymerase Chain Reaction (PCR) test turned negative * willing to participate in the study Exclusion Criteria: * having a history of chronic lung disease * unwilling to participate in the study

Locations (1)

Gazi University

Ankara, Çankaya, Turkey (Türkiye)

Outcomes

Primary Outcomes

Respiratory muscle strength

Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device.

Time frame: 10 minute

Secondary Outcomes

FEV1

Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1 will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal.

Time frame: 5 minute

FVC

Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FVC will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal

Time frame: 5 minute

FEV1/FVC

Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1/FVC will be evaluated.

Time frame: 5 minute

PEF

Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. PEF will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal.

Time frame: 5 minute

FEF2575

Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEF2575 will be evaluated. The percentage of predicted value \<50% will be expressed as abnormal.

Time frame: 5 minute

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.